Cholangiocarcinoma:
clarity in a complex disease
- Early recognition and high-quality molecular profiling are transforming how cholangiocarcinoma (CCA) is diagnosed and managed1
- Explore practical, evidence-based guidance to support confident, timely decision-making across the patient pathway
What is cholangiocarcinoma?What is CCA?1
- Cholangiocarcinoma is a rare bile duct cancer with rising incidence worldwide
- Diagnosis is often delayed because symptoms can be non-specific and the diagnostic pathway complex
- Increasing understanding of cholangiocarcinoma's molecular diversity highlights the importance of comprehensive molecular profiling to better inform care
Practical biopsy guidance
Select the most appropriate biopsy approach for different CCA scenarios to ensure samples are suitable for pathology and biomarker testing.
Clear molecular profiling know-how
Understand the biomarkers that matter, and the differences between profiling platforms.
A joined-up patient journey
Follow the steps from suspicion to sequencing and see the key roles across the multidisciplinary team.
Explore our selection of cholangiocarcinoma resources
Downloadable resources to help you diagnose and manage CCA.
Reference: 1. Banales JM, et al. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588.